Upgrade to SI Premium - Free Trial

Incyte's ruxolitinib cream gets positive EU review for eczema

June 26, 2026 7:30 AM
Incyte (Nasdaq: INCY) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA